CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 90 filers reported holding CYTOSORBENTS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $38,844 | -83.1% | 10,820 | -84.1% | 0.00% | – |
| Q1 2023 | $229,308 | +363.1% | 68,044 | +113.0% | 0.00% | – |
| Q4 2022 | $49,512 | +27.0% | 31,943 | +13.8% | 0.00% | – |
| Q3 2022 | $39,000 | -80.8% | 28,062 | -69.8% | 0.00% | – |
| Q2 2022 | $203,000 | +190.0% | 92,962 | +320.6% | 0.00% | – |
| Q1 2022 | $70,000 | -80.0% | 22,100 | -73.4% | 0.00% | – |
| Q4 2021 | $350,000 | -59.1% | 83,176 | -21.0% | 0.00% | – |
| Q3 2021 | $855,000 | -42.2% | 105,275 | -46.2% | 0.00% | – |
| Q2 2021 | $1,478,000 | -39.4% | 195,773 | -30.3% | 0.00% | – |
| Q1 2021 | $2,439,000 | +13.9% | 281,037 | +4.6% | 0.00% | – |
| Q4 2020 | $2,142,000 | +90.1% | 268,778 | +90.2% | 0.00% | – |
| Q3 2020 | $1,127,000 | -48.2% | 141,344 | -35.7% | 0.00% | – |
| Q2 2020 | $2,176,000 | +21.4% | 219,927 | -5.2% | 0.00% | – |
| Q1 2020 | $1,793,000 | +1056.8% | 232,055 | +476.1% | 0.00% | – |
| Q4 2019 | $155,000 | -30.8% | 40,283 | -9.7% | 0.00% | – |
| Q3 2019 | $224,000 | -70.3% | 44,594 | -60.9% | 0.00% | – |
| Q2 2019 | $753,000 | +286.2% | 114,010 | +342.1% | 0.00% | – |
| Q1 2019 | $195,000 | -44.6% | 25,787 | -5.5% | 0.00% | – |
| Q3 2018 | $352,000 | -46.1% | 27,300 | -52.4% | 0.00% | – |
| Q2 2018 | $653,000 | -55.9% | 57,300 | -72.7% | 0.00% | – |
| Q1 2018 | $1,480,000 | +68.2% | 209,919 | +54.9% | 0.00% | – |
| Q4 2017 | $880,000 | -39.5% | 135,509 | -42.3% | 0.00% | – |
| Q3 2017 | $1,455,000 | +112.7% | 234,704 | +47.4% | 0.00% | – |
| Q2 2017 | $684,000 | +53.0% | 159,234 | +60.6% | 0.00% | – |
| Q1 2017 | $447,000 | +118.0% | 99,142 | +163.3% | 0.00% | – |
| Q4 2016 | $205,000 | -51.5% | 37,647 | -43.0% | 0.00% | – |
| Q3 2016 | $423,000 | +20.2% | 66,100 | -14.4% | 0.00% | – |
| Q2 2016 | $352,000 | -8.8% | 77,248 | -21.6% | 0.00% | – |
| Q1 2016 | $386,000 | -61.8% | 98,497 | -45.7% | 0.00% | – |
| Q4 2015 | $1,011,000 | -6.5% | 181,469 | +5.9% | 0.00% | – |
| Q3 2015 | $1,081,000 | -19.6% | 171,300 | -21.4% | 0.00% | – |
| Q2 2015 | $1,345,000 | +131.9% | 218,069 | +396.3% | 0.00% | – |
| Q1 2015 | $580,000 | – | 43,938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |